PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26481311-7	2016	The integrity of this partnership may be clinically relevant, because hCNT3 may be responsible for the translocation of thiopurines, such as 6-mercaptopurine, a front-line treatment in inflammatory bowel disease.	Mercaptopurine	141-157	solute carrier family 28 member 3	Homo sapiens	70-75	
21723252-1	2011	Exposure of MOLT4 human T-cell leukemia cells to 6-Mercaptopurine (6-MP) and 6-Thioguanine (6-TG) resulted in acquired resistance associated with attenuated expression of the genes encoding concentrative nucleoside transporter 3 (CNT3) and equilibrative nucleoside transporter 2 (ENT2).	Mercaptopurine	49-65	solute carrier family 28 member 3	Homo sapiens	190-228	
23934611-7	2013	We also applied the models to pharmacogenomic studies for the drugs gemcitabine and 6-mercaptopurine and found that the diagonal degree model identified an association between 6-mercaptopurine response and expression of the gene SLC28A3, which was not detectable using the model including no pathway information.	Mercaptopurine	84-100	solute carrier family 28 member 3	Homo sapiens	229-236	
23934611-7	2013	We also applied the models to pharmacogenomic studies for the drugs gemcitabine and 6-mercaptopurine and found that the diagonal degree model identified an association between 6-mercaptopurine response and expression of the gene SLC28A3, which was not detectable using the model including no pathway information.	Mercaptopurine	176-192	solute carrier family 28 member 3	Homo sapiens	229-236	
21723252-1	2011	Exposure of MOLT4 human T-cell leukemia cells to 6-Mercaptopurine (6-MP) and 6-Thioguanine (6-TG) resulted in acquired resistance associated with attenuated expression of the genes encoding concentrative nucleoside transporter 3 (CNT3) and equilibrative nucleoside transporter 2 (ENT2).	Mercaptopurine	49-65	solute carrier family 28 member 3	Homo sapiens	230-234	
21723252-1	2011	Exposure of MOLT4 human T-cell leukemia cells to 6-Mercaptopurine (6-MP) and 6-Thioguanine (6-TG) resulted in acquired resistance associated with attenuated expression of the genes encoding concentrative nucleoside transporter 3 (CNT3) and equilibrative nucleoside transporter 2 (ENT2).	Mercaptopurine	67-71	solute carrier family 28 member 3	Homo sapiens	190-228	
21723252-1	2011	Exposure of MOLT4 human T-cell leukemia cells to 6-Mercaptopurine (6-MP) and 6-Thioguanine (6-TG) resulted in acquired resistance associated with attenuated expression of the genes encoding concentrative nucleoside transporter 3 (CNT3) and equilibrative nucleoside transporter 2 (ENT2).	Mercaptopurine	67-71	solute carrier family 28 member 3	Homo sapiens	230-234	
16530731-8	2006	Taken together these results show that CNT3 and ENT2 play a key role in the transport of 6-MP and 6-TG by leukemia cells.	Mercaptopurine	89-93	solute carrier family 28 member 3	Homo sapiens	39-43